Results 21 to 30 of about 15,859 (208)

Oligometastatic Prostate Cancer [PDF]

open access: yesCurrent Treatment Options in Oncology, 2016
The mainstay of treatment for men with three or fewer non-castrate metastatic lesions outside of the prostate remains morbid palliative androgen deprivation therapy. We believe there is now a significant body of retrospective literature to suggest a survival benefit if these men have radical treatment to their primary tumour alongside 'metastasis ...
Stevens, Daniel J.   +1 more
openaire   +2 more sources

Role of PSMA PET-guided metastases-directed therapy in oligometastatic recurrent prostate cancer

open access: yesFrontiers in Oncology, 2022
Oligometastatic prostate cancer (OMPC) has been proposed as an intermediary state between localised disease and widespread metastases, with varying definitions including 1, 3, or ≤5 visceral or bone metastasis.
Matthew Alberto   +9 more
doaj   +1 more source

Oligometastatic cancer

open access: yesOnkologija, 2022
Oligometastatic disease (OMD) is a stage between locally advanced disease and polymetastatic disease, a group of diseases that are used interchangeably based on treatment history, ongoing treatment status, and imaging findings. The diagnosis of OMD is based on imaging because, as of yet, we are not aware of any specific biomarkers that would enable us ...
Ivica Ratoša   +12 more
openaire   +2 more sources

Achieving Consensus for Management of Hormone-Sensitive, Low-Volume Metastatic Prostate Cancer in Italy

open access: yesCurrent Oncology, 2022
Metastatic hormone-sensitive prostate cancer (mHSPC) is usually categorized as high- or low-volume disease. This is relevant because low- and high-volume metastatic disease are associated with different outcomes, and thus management of the two forms ...
Elena Verzoni   +12 more
doaj   +1 more source

Definitive local therapy to head and neck squamous cell carcinoma with distant metastasis

open access: yesLaryngoscope Investigative Otolaryngology, 2022
Objectives Data on the efficacy of including definitive local therapy to the primary site for head and neck squamous cell carcinoma (HNSCC) patients with synchronous distant metastasis are lacking.
Steven Borson   +17 more
doaj   +1 more source

Highlighting the Place of Metastasis-Directed Therapy in Isolated Liver Metastases in Prostate Cancer: A Case Report

open access: yesFrontiers in Oncology, 2021
Metastatic prostate cancer remains a challenge for clinicians. Metastases involve mainly the bone compartment and can manifest as oligometastatic disease.
Anne-Emmanuella Yeo   +6 more
doaj   +1 more source

oligometastatic review

open access: yes, 2021
Meta-analysis of prognosis of oligometastatic ...
petrelli, F (via Mendeley Data)   +1 more
core   +1 more source

Highlights on the Management of Oligometastatic Disease [PDF]

open access: yesJournal of Immunotherapy and Precision Oncology, 2020
AbstractPurpose: The understanding of oligometastatic disease (OMD) is rapidly evolving and with this comes the ability to utilize a number of modalities that excel in the localized control of disease. It has been identified that there are no clear guidelines based on high-level evidence to standardized approaches toward the management of OMD.
Salem M. Alshehri   +13 more
openaire   +3 more sources

First-Line Tyrosine Kinase Inhibitors Combined With Local Consolidative Radiation Therapy for Elderly Patients With Oligometastatic Non-Small Cell Lung Cancer Harboring EGFR Activating Mutations

open access: yesFrontiers in Oncology, 2022
ObjectiveThe aim of this study was to investigate the efficacy and safety of combined applications of local consolidative radiation therapy (LCRT) and first-line tyrosine kinase inhibitors (TKIs) for the treatment of primary tumors and oligometastatic ...
Xiaolong Hu   +7 more
doaj   +1 more source

Survival benefit of local consolidative therapy for patients with single-organ metastatic pancreatic cancer: a propensity score-matched cross-sectional study based on 17 registries

open access: yesFrontiers in Endocrinology, 2023
BackgroundThe continuous exploration of oligometastatic disease has led to the remarkable achievements of local consolidative therapy (LCT) and favorable outcomes for this disease.
Xiaolong Hu   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy